Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

2020545 citationsJournal Articlegreen Open Access

Authors

Sorafenib maintenance therapy reduces the risk of relapse and death after HCT for <i>FLT3-</i>ITD-positive AML.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 38, Issue 26, pp. 2993-3002

Field-Weighted Citation Impact: 41.80